DA Davidson reiterated coverage on Natures Sunshine Products with a new price target
$NATR
Biotechnology: Pharmaceutical Preparations
Health Care
DA Davidson reiterated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $24.50 from $24.00 previously